STRATA Skin Sciences Files 8-K on Shareholder Vote

TL;DR

STRATA Skin Sciences held a shareholder vote on Oct 29, 2024. Details to follow.

AI Summary

STRATA Skin Sciences, Inc. filed an 8-K on October 30, 2024, to report on matters submitted to a vote of its security holders on October 29, 2024. The filing does not detail the specific proposals voted on or their outcomes, but it is a standard procedural filing related to shareholder meetings.

Why It Matters

This filing indicates that STRATA Skin Sciences held a shareholder meeting where votes were cast on important company matters. The outcome of these votes could impact the company's future direction and governance.

Risk Assessment

Risk Level: low — This is a routine procedural filing indicating a shareholder vote took place, without immediate financial or operational implications disclosed.

Key Players & Entities

• STRATA Skin Sciences, Inc. (company) — Registrant
• October 29, 2024 (date) — Date of earliest event reported
• October 30, 2024 (date) — Date of report
• Delaware (jurisdiction) — State of Incorporation
• 215 - 619-3200 (phone_number) — Registrant's telephone number

FAQ

Key Financial Figures

• $0.001 — ange on which registered Common Stock, $0.001 par value per share SSKN The NASDAQ

Filing Documents

• ef20037844_8k.htm (8-K) — 39KB
• image0.jpg (GRAPHIC) — 194KB
• 0001140361-24-044583.txt ( ) — 658KB
• sskn-20241029.xsd (EX-101.SCH) — 4KB
• sskn-20241029_lab.xml (EX-101.LAB) — 21KB
• sskn-20241029_pre.xml (EX-101.PRE) — 16KB
• ef20037844_8k_htm.xml (XML) — 4KB

07

ITEM 5.07 SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS On October 29, 2024 the Company held its annual meeting of stockholders (the "Annual Meeting"). The matters voted upon were: (1) the election of five director nominees to the Company's board of directors to serve until the next annual meeting of the Company's stockholders or until their successors are elected and qualify, subject to their prior death, resignation or removal; (2) to ratify the selection by the Audit Committee of the Board of Directors of Marcum, LLP as our independent registered public accounting firm for the (3) to approve other business as may properly come before the meeting. The results of the voting were as follows: (1) Each of the director nominees to the Company's board of directors was elected: Nominees Votes For Votes Withheld Broker Non-Vote Dr. Uri Geiger 2,308,422 141,987 1,039,279 Dr. Irit Yaniv 2,158,458 21,972 1,039,279 Christina Allgeier 2,308,422 141,987 1,039,279 Shmuel Rubinstein 2,173,350 7,080 1,039,279 Dr. Dolev Rafaeli 2,308,422 141,724 1,039,279 (2) to ratify the selection by the Audit Committee of the Board of Directors of Marcum, LLP as our independent registered public accounting firm for the Votes For Votes Against Abstain Broker Non-Vote 3,166,313 53,201 195 0 (3) to approve other business as may properly come before the meeting Votes For Votes Against Abstain Broker Non-Vote 1,944,264 232,596 3,569 1,039,279 -2- SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. STRATA SKIN SCIENCES, INC. Date: October 30, 2024 By: /s/ Dolev Rafaeli Dr. Dolev Rafaeli Chief Executive Officer -3-

View Full Filing

View this 8-K filing on SEC EDGAR